YD Bio Limited Ordinary Shares (NASDAQ: YDES) last traded at $4.69, down 2.00% on the session. The quote above updates while this page is open; the figures below are drawn from YD Bio Limited Ordinary Shares’s own filings and are restated only when a new one is published.
YD Bio Limited Ordinary Shares trades on NASDAQ under the ticker YDES. Its market capitalisation is $332.00 million.
Valuation measures for YD Bio Limited Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $332.00M |
|---|---|
| Enterprise value | $342.63M |
| Price / sales | 556.29 |
| Beta | 0.01 |
Trailing-twelve-month figures tagged in YD Bio Limited Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $596.8K |
|---|---|
| Net income (TTM) | -$8.31M |
| EPS (TTM) | -$0.120 |
| Gross margin | 28.05% |
| Operating margin | -883.31% |
| Cash | $6.01M |
Range and volume for YDES over the past 52 weeks.
| 52-week high | $25.00 |
|---|---|
| 52-week low | $1.70 |
| Volume | 35.3K |
| Average volume | 138.8K |
| Previous close | $4.79 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.